Science Explorer Back to mapMap
Discussion

NeoGenomics (United States)

In research, NeoGenomics (United States) stands highest in Health Sciences (#15,750 of 16,688 worldwide) and Medicine (#13,850 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology (Biochemistry, Genetics and Molecular Biology is 7.0× its share of world research).

World rank, 2022-now
#21,961
of 22,385 · #34,145 all time
Rank in United States
#3,260
of 3,332
Research works
271
▲ 5% vs 2018-21
Citations
3k
11.0 per fractional work
Top-10% rate
6.7%
all institutions 10.0%
vs its own fields
0.88×
1.00× is exactly expected
Open access
31%
world 40%
International
20%
world 18%

What is NeoGenomics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #15,750 of 16,688 9.7%136
MedicineField #13,850 of 14,558 9.7%134

Each strip is that field's whole ranked pool, with the notch where NeoGenomics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does NeoGenomics (United States) work in?

In 2022-now, 43% of research at NeoGenomics (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (37%), Computer Science (6%). It does 2.8× the world's share of Life Sciences.

Health Sciences: 48 fractional works · 43.4% of its workMedicine: 47 fractional works · 42.8% of its workOncology: 10 fractional works · 9.4% of its workPulmonary and Respiratory Medicine: 7 fractional works · 6.3% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 4.9% of its workHematology: 4 fractional works · 3.7% of its workGenetics: 4 fractional works · 3.7% of its workPathology and Forensic Medicine: 3 fractional works · 2.9% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.0% of its workSurgery: 2 fractional works · 1.4% of its workPhysiology: 1 fractional works · 1.2% of its workReproductive Medicine: 1 fractional works · 1.1% of its workRheumatology: 1 fractional works · 1.0% of its workEpidemiology: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.2% of its workLife Sciences: 47 fractional works · 42.3% of its workBiochemistry, Genetics and Molecular Biology: 41 fractional works · 37.1% of its workMolecular Biology: 17 fractional works · 15.2% of its workCancer Research: 15 fractional works · 13.3% of its workGenetics: 5 fractional works · 4.1% of its workBiotechnology: 3 fractional works · 3.0% of its workBiophysics: 1 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 3.2% of its workImmunology: 4 fractional works · 3.2% of its workNeuroscience: 2 fractional works · 1.6% of its workNeurology: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPhysical Sciences: 13 fractional works · 12.0% of its workComputer Science: 7 fractional works · 6.3% of its workArtificial Intelligence: 2 fractional works · 1.8% of its workComputer Networks and Communications: 2 fractional works · 1.5% of its workComputer Vision and Pattern Recognition: 2 fractional works · 1.4% of its workComputational Theory and Mathematics: 1 fractional works · 0.9% of its workInformation Systems: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 4 fractional works · 3.6% of its workBiomedical Engineering: 2 fractional works · 2.0% of its workIndustrial and Manufacturing Engineering: 1 fractional works · 1.0% of its workAerospace Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 0.9% of its workSpectroscopy: 1 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 0.6% of its workPollution: 0 fractional works · 0.2% of its workGlobal and Planetary Change: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workAstronomy and Astrophysics: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 2.3% of its workSocial Sciences: 1 fractional works · 1.3% of its workPolitical Science and International Relations: 0 fractional works · 0.5% of its workTransportation: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKNeoGenomics(United States)111fractional works, 2022-now
Life Sciences42%Physical Sciences12%Health Sciences43%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine4742.8%
    2. Health Professions00.3%
    3. Dentistry00.2%
    4. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology4137.1%
    2. Immunology and Microbiology43.2%
    3. Neuroscience21.6%
    4. Agricultural and Biological Sciences00.4%
    1. Computer Science76.3%
    2. Engineering43.6%
    3. Chemistry10.9%
    4. Environmental Science10.6%
    5. Physics and Astronomy00.2%
    6. Energy00.2%
    7. Earth and Planetary Sciences00.1%
    8. Mathematics00.1%
    1. Social Sciences11.3%
    2. Economics, Econometrics and Finance00.4%
    3. Psychology00.3%
    4. Decision Sciences00.3%
    5. Arts and Humanities00.1%
    6. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does NeoGenomics (United States) specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 7.0× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 41.0 works7.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.08× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.96× its world share, 41 worksBiochemistry, Geneti…Immunology and Microbiology: 3.17× its world share, 4 worksImmunology and Micro…Neuroscience: 0.97× its world share, 2 worksNeuroscienceChemistry: 0.58× its world share, 1 worksChemistryComputer Science: 0.81× its world share, 7 worksComputer ScienceEarth and Planetary Sciences: 0.06× its world share, 0 worksEarth and Planetary …Energy: 0.16× its world share, 0 worksEnergyEngineering: 0.24× its world share, 4 worksEngineeringEnvironmental Science: 0.11× its world share, 1 worksEnvironmental ScienceMathematics: 0.08× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyDentistry: 0.44× its world share, 0 worksDentistryHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 2.22× its world share, 47 worksMedicineNursing: 0.31× its world share, 0 worksNursingArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.26× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 0 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.0×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology6.96×41 works
  2. Immunology and Microbiology3.17×4 works
  3. Medicine2.22×47 works
  4. Neuroscience0.97×2 works
  5. Computer Science0.81×7 works
  6. Chemistry0.58×1 works
  7. Dentistry0.44×0 works
  8. Nursing0.31×0 works
  9. Decision Sciences0.26×0 works
  10. Engineering0.24×4 works
  11. Energy0.16×0 works
  12. Economics, Econometrics and Finance0.16×0 works
  13. Environmental Science0.11×1 works
  14. Health Professions0.11×0 works
  15. Psychology0.10×0 works
  16. Social Sciences0.10×2 works
  17. Physics and Astronomy0.09×0 works
  18. Agricultural and Biological Sciences0.08×0 works
  19. Mathematics0.08×0 works
  20. Earth and Planetary Sciences0.06×0 works
  21. Arts and Humanities0.02×0 works
  22. Business, Management and Accounting0.02×0 works

Who are the top researchers at NeoGenomics (United States)?

Ranked on the quality score, Christodoulos Pipinikas, Vincent Anthony Funari and Anna Juncker‐Jensen lead among researchers whose main affiliation is NeoGenomics (United States).

  1. 1 Christodoulos Pipinikas United States · #345,583 worldwide 1.5k citations · 74 works
  2. 2 Vincent Anthony Funari United States · #357,149 worldwide 6.2k citations · 114 works
  3. 3 Anna Juncker‐Jensen United States · #1,006,880 worldwide 1.1k citations · 68 works
  4. 4 Sucha Sudarsanam United States · #1,481,164 worldwide 11k citations · 40 works
  5. 5 Samuel Koo United States · #1,551,118 worldwide 1.1k citations · 27 works
  6. 6 Harry Nunns United States · #1,608,398 worldwide 241 citations · 68 works
  7. 7 Josette William United States · #1,961,638 worldwide 1.1k citations · 30 works
  8. 8 Fernando J. López-Díaz United States · #2,059,667 worldwide 691 citations · 48 works
  9. 9 Segun C. Jung United States · #2,297,311 worldwide 1.1k citations · 52 works
  10. 10 Madhuri Paul United States · #2,853,372 worldwide 66 citations · 90 works
All ranked researchers at NeoGenomics (United States)

What are the most cited papers from NeoGenomics (United States)?

The most cited paper from NeoGenomics (United States) is "Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project" (Diana M. Merino et al., 2020), with 516 citations. Next come "Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice" (407) and "Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia" (347).

Most cited papers
#PaperReleasedCitations
1 Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project Diana M. Merino et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2020 516
2 Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice Maxime Cazorla, Joël Prémont, André Mann et al. · Journal of Clinical Investigation Open access 18 Apr 2011 407
3 Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia Inhye E. Ahn, Chingiz Underbayev, Adam Albitar et al. · Blood Open access 3 Jan 2017 347
4 Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models James G. Taylor et al. · Journal of Clinical Investigation Open access 5 Oct 2009 322
5 Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry Donald H. Chace, Steven L Hillman, Johan L.K. Van Hove et al. · Clinical Chemistry Nov 1997 284
All 61 most cited papers, with filters and sorting

Which keywords describe research at NeoGenomics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Genomic Instability, Cancer Genomics, Mutational Signatures, Immunotherapy, Gene Expression and Prognostic Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy13▲ 51×4 topics
  2. Cell-Free DNA10▲ 92×2 topics
  3. Genomic Instability10▲ 79×2 topics
  4. Cancer Genomics10▲ 124×1 topic
  5. Mutational Signatures10▲ 124×1 topic
  6. Immunotherapy8▲ 9.4×11 topics
  7. Gene Expression7▲ 10×9 topics
  8. Prognostic Factors7▲ 15×7 topics
  9. Tumor Microenvironment7▲ 14×6 topics
  10. Machine Learning7▲ 1.87×8 topics
  11. Cancer7▲ 4.6×18 topics
  12. Chemotherapy6▲ 7.7×11 topics
  13. Tumor Targeting5▲ 24×2 topics
  14. Gene Therapy5▲ 22×3 topics
  15. Precision Medicine4▲ 8.2×4 topics
  16. Nanoparticles4▲ 3.1×5 topics
  17. Clinical Trials4▲ 5.3×7 topics
  18. Breast Cancer4▲ 14×9 topics
  19. Biomarkers4▲ 4.8×9 topics
  20. Tumor Regression4▲ 30×2 topics
  21. Quantitative Analysis3▲ 15×2 topics
  22. Arginine Deprivation3▲ 77×1 topic
  23. Bacterial Therapy3▲ 77×1 topic
  24. Immune Checkpoint Blockade3▲ 26×1 topic
  25. PD-1 and PD-L13▲ 26×1 topic
  26. Rituximab3▲ 20×2 topics
  27. Feature Extraction3▲ 6.1×2 topics
  28. Texture Analysis3▲ 13×2 topics
  29. Hematopoietic Stem Cells3▲ 30×3 topics
  30. Metastasis3▲ 7.4×5 topics
  31. Radiomics3▲ 21×1 topic
  32. AML3▲ 49×1 topic
  33. Acute Myeloid Leukemia3▲ 49×1 topic
  34. Data Analysis2▲ 8.5×3 topics
  35. PET Imaging2▲ 14×3 topics
  36. High-Throughput Analysis2▲ 58×1 topic
  37. Protein Microarrays2▲ 118×1 topic
  38. Genomic Profiling2▲ 19×2 topics
  39. Molecular Profiling2▲ 21×3 topics
  40. Transcriptional Regulation2▲ 12×3 topics

Which research topics does NeoGenomics (United States) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers and Radiomics and Machine Learning in Medical Imaging.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 10 works
  2. 2 Cancer Research and Treatments Biotechnology 3 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 3 works
  4. 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
  5. 5 Acute Myeloid Leukemia Research Hematology 3 works
  6. 6 Advanced Biosensing Techniques and Applications Molecular Biology 2 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 2 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
  9. 9 Single-cell and spatial transcriptomics Molecular Biology 2 works
  10. 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.6%not open69.4%

World: 40% of research is openly available.

with international co-authors20.5%domestic only79.5%

World: 18% is written across borders.

How has NeoGenomics (United States)'s research output changed?

Output in 2022-2025 was 5% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is NeoGenomics (United States) as a percentage of every work published that year, 0.00050% in 2024.

still counting0.00020%0.00040%0.00060%NeoGenomics (United States)0.00029% in 2025200020102020

Fractional works of NeoGenomics (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%all institutions10.0% in 2024NeoGenomics (United States)6.9% in 20242020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.3% in 2021.

Other research institutions in Aliso Viejo

All research institutions in Aliso Viejo

Share NeoGenomics (United States)'s ranking

NeoGenomics (United States) on Science Explorer

A card with NeoGenomics (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NeoGenomics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.